Many Survivors Jobless After Respiratory Distress Syndrome

This article originally appeared here.
Share this content:
Many Survivors Jobless After Respiratory Distress Syndrome
Many Survivors Jobless After Respiratory Distress Syndrome

WEDNESDAY, May 3, 2017 (HealthDay News) -- Nearly half of previously employed acute respiratory distress syndrome (ARDS) survivors are jobless one year after hospital discharge, according to a study published online April 27 in the American Journal of Respiratory and Critical Care Medicine.

Biren B. Kamdar, M.D., M.B.A., M.H.S., from the David Geffen School of Medicine at the University of California, Los Angeles, and colleagues examined the timing of return to work after ARDS during a 12-month longitudinal follow-up. Employment and health care coverage data were provided by ARDS survivors from 43 U.S. ARDSNet hospitals via telephone interviews.

The researchers found that 42 percent of the 922 consenting survivors were employed before ARDS, with seven dying by 12-month follow-up. At 12-month follow-up, 44 percent of 379 previously employed 12-month survivors were jobless. Half of enrolled and previously employed survivors returned to work by 13 weeks after hospital discharge after the researchers accounted for competing risks of death and retirement; 68 percent ever returned by 12 months. Among nonwhite survivors, delays in return to work correlated with longer hospitalization and older age. Seventy-one percent of survivors accrued lost earnings over 12-month follow-up, averaging $26,949 ± $22,447 (60 percent of pre-ARDS annual earnings). Jobless survivors experienced a 14 percent absolute decrease and a 16 percent absolute increase in private health insurance and Medicare and Medicaid, respectively.

"Post-ARDS joblessness is associated with readily identifiable patient and hospital variables, and accompanied by substantial lost earnings and a shift toward government-funded health care coverage," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Zika Does Not Appear to Last in Semen As Long As Thought

Zika Does Not Appear to Last in Semen ...

More research is needed to better inform public health recommendations

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke Risk

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke ...

I-131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke

Higher Odds of Infection With Reduced Kidney Function

Higher Odds of Infection With Reduced Kidney Function

Study finds excess community-acquired infections incidence in individuals with mild to severe CKD

is free, fast, and customized just for you!

Already a member?

Sign In Now »